2Szoke K,Sapy T,Krasznai Z,et al.Moderate Variation of the oncogenic potential among high-risk Human papilloma Virus types in gynecologic patients with cervical abnormalities.J Med Virol,2003,71(4):585-592.
2Rober JK,Diane S.The Bethesda system for reporting cervical/vaginal cytologic diagnoses.New York :Springer-Verlag,1993.1-81.
3Diane S, Diane D, Robert K, et al. The 2001 Bethesda System Terminnology for Reporting Results of Cervical Cytology. JAMA,2002,287:2114-2119.
4Naryshkin S.The false-negative fraction for Papanicolaou smears: how often are ''abnormal'' smears not detected by a ''standard screening cytologist?''.Arch Pathol Lab Med,1997,121:270-272.
5Hatem F,Wibur D. High-grade squamous intrarpthelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears : screening failures of rapid progression? Mod Pathol, 1992,5:337-342.
6Drijkningen M, Meertens B,Lauweryns J. High-grade squamous intraepithelial lesion(CIN3) with extension into the endocervical clefts: difficulty of cytologic differentiation from adenocarcinoma in situ. Acta Cytol,1996,40:889-894.
7Laverty CR, Farnsworth A,Thurloe JK, et al.Evalustion of the Cytorich slide preparation processs. Anal Quant Cytol Histol ,1997,19:239-245.
8Wilbur DC, Facik MS, Rutkowski MA,et al.Clinical trials of the CytoRich specimen-preparation device for cervical cytology.Preliminary results.Acta Cytol,1997,41:24-29.
9Mark E, Sherman,MD, Sana O, et al.''ASCUS, Rule Out HSIL'': Cytologic Features,Histologic Correlates, and Human Papillomavirus Detection.Int J Med,2000,4:7-13.
10Kline MJ, Davey D. Atypical squamous cells of undetermined significance qualified: a follow-up study. Diagn Cytopathol,1996,14:380-384.